17948, Mahanoy City, Pennsylvania Prostate Cancer Score Provider Score

The Provider Score for the Prostate Cancer Score in 17948, Mahanoy City, Pennsylvania is 43 when comparing 34,000 ZIP Codes in the United States.

An estimate of 87.29 percent of the residents in 17948 has some form of health insurance. 51.72 percent of the residents have some type of public health insurance like Medicare, Medicaid, Veterans Affairs (VA), or TRICARE. About 47.11 percent of the residents have private health insurance, either through their employer or direct purchase. Military veterans should know that percent of the residents in the ZIP Code of 17948 have VA health insurance. Also, percent of the residents receive TRICARE.

For the 1,100 residents under the age of 18, there is an estimate of 6 pediatricians in a 20-mile radius of 17948. An estimate of 5 geriatricians or physicians who focus on the elderly who can serve the 659 residents over the age of 65 years.

In a 20-mile radius, there are 1,784 health care providers accessible to residents in 17948, Mahanoy City, Pennsylvania.

Analyzing prostate cancer care within ZIP code 17948, encompassing Mahanoy City, necessitates a multifaceted approach. We must assess not only the availability of urologists and specialists but also the broader healthcare infrastructure supporting patient well-being. This analysis focuses on physician access, technological integration, and the crucial element of mental health support, ultimately aiming to provide a comprehensive 'Prostate Cancer Score' evaluation.

Mahanoy City, a community with a population of approximately 4,000, presents unique challenges and opportunities in healthcare delivery. The area’s demographics, potentially including a higher proportion of older adults, underscore the importance of readily accessible prostate cancer screening and treatment options. The 'Prostate Cancer Score' will reflect the degree to which the local healthcare system meets these specific needs.

Physician-to-patient ratios are a critical metric. A low ratio of urologists to the overall population can significantly impede timely diagnosis and treatment. While precise figures for Mahanoy City alone are difficult to obtain, we can extrapolate from county-level data and regional trends. This analysis will incorporate estimates of urologist availability within a reasonable driving distance, considering factors such as travel time and access to public transportation. The score will penalize areas with limited access to specialists.

Beyond urologists, the availability of primary care physicians (PCPs) is crucial. PCPs often serve as the initial point of contact for men experiencing symptoms suggestive of prostate cancer. A robust network of PCPs facilitates early screening, referrals to specialists, and ongoing management of the disease. The 'Prostate Cancer Score' will incorporate the density of PCPs in the area and their demonstrated commitment to preventative care, including prostate cancer screening.

Standout practices within the region will be identified based on several criteria. These include the adoption of advanced diagnostic technologies, such as MRI and advanced biopsy techniques. Practices that demonstrate a commitment to patient-centered care, including clear communication and shared decision-making, will also receive higher marks. Furthermore, practices with a track record of positive patient outcomes and adherence to established clinical guidelines will be recognized.

Telemedicine adoption is increasingly important, particularly in rural or underserved areas. Telemedicine offers several advantages, including the ability to connect patients with specialists remotely, reduce travel burdens, and improve access to follow-up care. The 'Prostate Cancer Score' will evaluate the extent to which local healthcare providers utilize telemedicine for prostate cancer consultations, monitoring, and patient education. Practices actively embracing telehealth will be viewed favorably.

Mental health resources are an often-overlooked but essential component of prostate cancer care. A diagnosis of prostate cancer can be emotionally challenging, leading to anxiety, depression, and other mental health concerns. The 'Prostate Cancer Score' will assess the availability of mental health services in the area, including access to therapists, counselors, and support groups. Practices that integrate mental health support into their care plans will be recognized for their holistic approach.

The evaluation of mental health resources will consider the availability of both in-person and telehealth options. The score will also factor in the integration of mental health screenings into routine care and the availability of educational materials and support groups specifically tailored to men with prostate cancer and their families. The goal is to ensure that patients receive comprehensive support throughout their cancer journey.

Specific practices within the area will be analyzed based on publicly available information, patient reviews, and any available data on their commitment to prostate cancer care. This includes examining their websites, online profiles, and any published reports on their performance. The 'Prostate Cancer Score' will reflect a comprehensive assessment of each practice's strengths and weaknesses, providing a valuable resource for patients seeking care.

The analysis will also consider the availability of resources for financial assistance and patient navigation. Prostate cancer treatment can be expensive, and many patients may require help navigating the complexities of insurance coverage and financial aid programs. Practices that offer assistance with these issues will be viewed more favorably. Patient navigation services can also help coordinate care and provide support throughout the treatment process.

The 'Prostate Cancer Score' will be a dynamic assessment, subject to change as healthcare providers adapt to evolving medical advancements and patient needs. Regular updates will be necessary to reflect changes in physician availability, telemedicine adoption, and the availability of mental health resources. The goal is to provide an ongoing evaluation of the quality of prostate cancer care in Mahanoy City and the surrounding area.

The final 'Prostate Cancer Score' will be presented in a clear and concise format, providing an overall rating for the area and individual ratings for key components of care. This will enable patients to make informed decisions about their healthcare and empower them to advocate for their needs. The score will also serve as a benchmark for healthcare providers, encouraging them to continuously improve the quality of care they provide.

This analysis is intended to provide a starting point for understanding prostate cancer care in Mahanoy City. It is crucial for individuals to consult with their primary care physicians and specialists to discuss their specific needs and treatment options. The 'Prostate Cancer Score' is a tool to help patients navigate the healthcare system and make informed decisions about their health.

To further explore the healthcare landscape of Mahanoy City and visualize the geographical distribution of healthcare resources, including physician locations, hospital access, and other relevant data, we encourage you to explore CartoChrome maps. CartoChrome maps offer interactive visualizations and data-driven insights that can enhance your understanding of healthcare accessibility and inform your healthcare decisions.